ResMed is a global leader in digital health and cloud-connected medical devices, focused on AI-powered digital health solutions, cloud-connected devices and intelligent software to make home healthcare more personalized, accessible, and effective.

# ResMed Inc. and Subsidiaries

## Core business and leadership
- Global leader in digital health and cloud-connected medical devices.
- Focused on AI-powered digital health solutions, cloud-connected devices, and intelligent software.
- Aims to make home healthcare more personalized, accessible, and effective.
- Objectives include improving quality of life, reducing the impact of chronic disease, and lowering costs for consumers and healthcare systems.

## History and primary product focus
- Founded in 1989; pioneered continuous positive airway pressure (CPAP) therapy as the first successful non-invasive treatment for obstructive sleep apnea (OSA).
- CPAP systems deliver pressurized air through a mask to prevent airway collapse during sleep.
- Expanded product portfolio through internal development and acquisitions to address a broad range of sleep and related breathing health disorders.

Product areas include:
- Technologies for medical and consumer products
- Life support and ventilation devices
- Diagnostic products
- Hospital and home mask systems, headgear, and accessories
- Dental devices

## Cloud, software, and connected care
- Strong emphasis on cloud-based health applications, software, and connected devices.
- Solutions are designed to help clinicians manage more patients efficiently and to support patients’ long-term adherence and satisfaction with therapy.

## Notable acquisitions and portfolio expansion
- In June 2026, ResMed acquired Noctrix Health, LLC, a company with an FDA De Novo classified medical device for restless legs syndrome.
- Noctrix will operate as a wholly owned subsidiary of ResMed.
- The acquisition expands the clinical sleep health portfolio into an adjacent unmet need.
- Further details are included in Note 18 – Business Combinations and Divestitures of the Notes to Consolidated Financial Statements.

ResMed Inc. is a global leader in digital health and cloud-connected medical devices, specializing in solutions for sleep-disordered breathing and chronic obstructive pulmonary disease.

# ResMed Inc.

## Company profile
- Founded: 1989  
- Headquarters: San Diego, California, USA  
- Website: [www.resmed.com](http://www.resmed.com)

## Business segments
ResMed operates across two main segments:
1. Sleep and Respiratory Care
2. Software as a Service (SaaS)

## Products and services
- Medical devices:
  - Continuous Positive Airway Pressure (CPAP) devices, including the AirSense and AirMini platforms
  - Bilevel devices
  - Ventilation devices for invasive and non-invasive use
  - Diagnostic products such as ApneaLink Air and NightOwl
- Software solutions:
  - AirView (remote patient monitoring)
  - myAir (patient engagement)
  - Brightree and HEALTHCAREfirst (home healthcare management)

## Workforce and global reach
- Total employees: Approximately 9,980  
- Countries: Products sold in over 140 countries  
- Customer base: Supports out-of-hospital care providers serving over 150 million individual patient accounts

## Financial performance
- Fiscal year 2024 revenue: Approximately $3.1 billion  
- Net income (FY2024): $633 million  
- Revenue mix:
  - Devices: ~52% of total net revenues (FY2024 and FY2022)
  - SaaS: ~12% of total net revenues

## Strategic goals
- Expand product development and innovation for sleep apnea and respiratory care
- Broaden the digital health technology foundation through advanced software solutions
- Enhance SaaS offerings to improve efficiency across out-of-hospital care settings
- Expand geographic presence in high-growth regions
- Increase public and clinical awareness about sleep apnea and COPD treatments

## Market presence and competitive position
ResMed serves millions of patients worldwide and competes with companies such as Philips and Fisher & Paykel. The company maintains a leadership position through ongoing product development and integration of digital health technologies.

## Compliance and regulatory environment
As a medical device manufacturer, ResMed complies with regulations from authorities including the U.S. FDA and the European Union Medical Device Regulations. The company manages quality standards across production and product safety.

## Key risks
Key risks include competition, potential product recalls, regulatory changes, manufacturing disruptions, and cybersecurity threats.

RESMED INC

10-K / August 13, 2026

10-K / August 9, 2024

10-K / August 13, 2026

ResMed Inc. and Subsidiaries

Core business and leadership

History and primary product focus

Cloud, software, and connected care

Notable acquisitions and portfolio expansion